Cel-Sci
CVM
#9766
Rank
HK$0.40 B
Marketcap
HK$50.19
Share price
2.54%
Change (1 day)
-61.61%
Change (1 year)

Cel-Sci (CVM) - Cash on Hand

Cash on Hand as of June 2025 : HK$13.95 Million

According to Cel-Sci 's latest financial reports the company has HK$13.95 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Cel-Sci - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-09-30HK$36.83 M13.46%
2023-09-30HK$32.46 M-81.76%
2022-09-30HK$0.17 B-45.85%
2021-09-30HK$0.32 B173.45%
2020-09-30HK$0.12 B81.58%
2019-09-30HK$66.19 M-17.99%
2018-09-30HK$80.7 M336.15%
2017-09-30HK$18.5 M-18.24%
2016-09-30HK$22.63 M-49%
2015-09-30HK$44.37 M-32.86%
2014-09-30HK$66.1 M20382.96%
2013-09-30HK$0.32 M-98.94%
2012-09-30HK$30.55 M-7.94%
2011-09-30HK$33.19 M-83.9%
2010-09-30HK$0.20 B-20.75%
2009-09-30HK$0.26 B3575.3%
2008-09-30HK$7.07 M-91.71%
2007-09-30HK$85.41 M35.66%
2006-09-30HK$62.95 M314.47%
2005-09-30HK$15.19 M-54.29%
2004-09-30HK$33.23 M144.58%
2003-09-30HK$13.58 M-16.21%
2002-09-30HK$16.21 M-12.53%
2001-09-30HK$18.54 M-77.71%
2000-09-30HK$83.16 M81.58%
1999-09-30HK$45.8 M-52.71%
1998-09-30HK$96.86 M257.64%
1997-09-30HK$27.08 M0.07%
1996-09-30HK$27.06 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Curis
CRIS
HK$70.43 M 404.84%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
HK$1.65 B 11,773.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$73.49 B 526,711.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
HK$3.66 B 26,173.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$17.14 B 122,776.30%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Johnson & Johnson
JNJ
HK$144.44 B 1,035,229.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
HK$1.91 B 13,593.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
HK$23.71 M 69.95%๐Ÿ‡บ๐Ÿ‡ธ USA